- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Industry News: Siemens unveils economical, high performance PET/CT
Siemens cast its work-in-progress 16-slice PET/CT at the nexus of vision and value.
Siemens cast its fledgling 16-slice PET/CT at the nexus of vision and value. The latest development, unveiled as a work-in-progress at ECR 2009 slated to enter the Biograph TruePoint PET/CT family, is being designed with high-end PET technology and value oriented 16-slice CT. For the most part, CT provides the anatomical context in which to interpret PET. The CT component, therefore, need not provide much more capability than is found on 16-slice CTs, if customers have only routine radiological or – more likely – oncological applications in mind.
Michael Reitermann, CEO of Siemens molecular imaging, described the new hybrid as a balance between innovation and access. It promotes the company’s vision to facilitate “universal adoption of PET/CT” by keeping the cost of the system as low as possible, Reitermann said, yet still delivers high-performance PET imaging. Whole body exams can be routinely accomplished in ten minutes with the advanced technologies built into the High-Definition PET component, he said.
The Biograph portfolio of PET/CT imagers now offers options with six-, 16-, 40- and 64-slice CT configurations. The premium performance line of hybrids, Siemens’ Biograph mCT, features 40-, 64- and 128-CT slice capabilities.
ECR Study Finds Mixed Results with AI on Breast Ultrasound
March 6th 2024While adjunctive use of AI led to significantly higher specificity and accuracy rates in detecting cancer on breast ultrasound exams in comparison to unassisted reading by breast radiologists, researchers noted that 12 of 13 BI-RADS 3 lesions upgraded by AI were ultimately benign, according to research presented at the European Congress of Radiology.
Can Autonomous AI Help Reduce Prostate MRI Workloads Without Affecting Quality?
March 1st 2024Based on findings from a multicenter study of over 1,600 patients, researchers at the European Congress of Radiology suggest the inclusion of autonomous artificial intelligence (AI) triage could facilitate up to a 75 percent reduction in prostate MRI reading workload.
Five Insights on Artifacts and Limitations with Contrast-Enhanced Mammography
February 29th 2024Noting that technique issues, patient positioning miscues and atypical features can all contribute to faulty interpretation with contrast-enhanced mammography (CEM), researchers at the European Congress of Radiology shared their insights on navigating artifacts and limitations with CEM.
ECR Study Examines Key Predictive Factors for Metastasis in Patients with High-Risk Prostate Cancer
February 28th 2024Sixty-five percent of patients with newly diagnosed high-risk prostate cancer may have extraprostatic extension on MRI, and PSMA PET/CT findings suggest those with Gleason scores of eight or higher have more than double the risk of metastasis, according to a new study presented at the European Congress of Radiology (ECR).
